Homoeopathic treatment for chronic shoulder pain

Management of chronic shoulder pain in adults with individualized homoeopathic medicines: A double-blind, randomized, placebo-controlled trial - NA

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064363

Enrollment

Registered

2024-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M255- Pain in joint

Interventions

Intervention1: Individualized homeopathic medicines in centesimal potencies plus concomitant care: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies (cH

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

dosage and repetition will be decided depending upon the individual requirement of the cases. All sundry items will be procured from a Good Manufacturing Practice (GMP) certified firm. All the enrolle

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with chronic shoulder pain for 3 months or more according to ICD 10 (M25.51) 2. Patients already undergoing regular oral or topical analgesics or NSAID therapy for chronic shoulder pain, provided the medications are stopped completely at least 2 weeks prior study entry 3. Age between 18 and 65 years 4. Patients of either both sex and transgender 5. Participants having prior experience or knowledge of the treatment; e.g., primed to expect ‘homoeopathic aggravation’ and available treatment options for the disease conditions, intimated through Patient Information Sheet.

Exclusion criteria

Exclusion criteria: 1. Not providing informed consent of participation 2. Radiological evidence of shoulder joint fracture or dislocation 3. Non-ambulant patients 4. Intra-articular injections within 2 weeks before study entry 5. Cases willing for or requiring immediate surgical intervention or already underwent any major shoulder joint surgery within last 3 months, 6. When the shoulder pain is due to any invasive malignant disease or neoplasia 7. Patients suffering from active local infection of shoulder joint, 8.Patients who are too sick for consultation 8. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life 9. Pregnancy, puerperal women and lactating mother 10. Tobacco chewing and/or smoking, alcoholism and/or any form(s) of substance abuse and/or dependence (TAPS tool) 11. Self-reported immune-compromised state, AIDS, hepatitis etc. 12. Undergoing homoeopathic treatment for any chronic disease within last 6 months 13. Simultaneous participation in any other clinical trial

Design outcomes

Primary

Measure	Time frame
Quick DASH (disabilities of the arm, shoulder, and hand)Timepoint: Baseline, every month, up to 3 months	—

Secondary

Measure	Time frame
10 cm visual analog scale measuring intensity of painTimepoint: Daily, via online survey, upto 3 months;Measure Yourself Medical Outcome Profile, version 2.0 (MYMOP-2)Timepoint: Baseline, every month, up to 3 months;Shoulder pain and disability index (SPADI)Timepoint: Baseline, every month, up to 3 months	—

Countries

India

Contacts

Public ContactSanjib Sarkar

D.N.DE HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

sanjibsarkar1102@gmail.com9903701819

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026